ESC 365 - How common is ATTR cardiac amyloidosis in aortic stenosis and how does it impact on management?

ESC Professional Premium Access

How common is ATTR cardiac amyloidosis in aortic stenosis and how does it impact on management?

Session: Management of cardiac transthyretin amyloidosis with or without aortic stenosis

Topic: Treatment

Speaker: Doctor T. Treibel (London, GB)

Event: ESC Congress 2022

Congress Presentation

About the speaker

Doctor Thomas Treibel

Barts Health NHS Trust, London (United Kingdom of Great Britain & Northern Ireland)

4 presentations

1 follower

3 more presentations in this session

What is ATTR cardiac amyloidosis and how is it diagnosed?

Speaker: Doctor M. Corneli (Buenos Aires, AR)

How should ATTR cardiac amyloidosis cardiomyopathy be treated?

Speaker: Professor T. Damy (Creteil, FR)

Management of cardiac transthyretin amyloidosis with or without aortic stenosis – discussion.

Access the full session

Management of cardiac transthyretin amyloidosis with or without aortic stenosis

Speakers: Doctor T. Treibel, Doctor M. Corneli, Professor T. Damy

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by